期刊文献+

产后出血患者血钙浓度与预防使用欣母沛的相关性探讨 被引量:12

Discussion of the correlation between blood calcium concentration of patients with postpartum hemorrhage and prophylactic administration of Hemabate
原文传递
导出
摘要 目的:探讨血钙浓度与欣母沛在预防产后出血中的协同作用。方法:选择2009年12月~2011年7月在常州市妇幼保健院分娩,并用欣母沛预防产后出血患者39例,按血清钙浓度分为两组:正常钙组11例,低血钙组28例。比较两组患者术中出血量,应用欣母沛治疗后24 h累计出血量、产后出血发生率、欣母沛用量。结果:低钙组产妇与正常钙组产妇在术中出血量,应用欣母沛治疗后24 h累计出血量、产后出血发生率、欣母沛使用量方面比较,差异均具有统计学意义(P<0.01)。结论:血钙浓度与欣母沛在预防产后出血中具有协同作用。 Objective: To explore the synergetic effects of blood calcium concentration and Hemabate for preventing postpartum hemorrhage. Methods: A total of 39 patients who gave birth to their babies and were treated with Hemabate to prevent postpartum hemorrhage in the hospital from December 2009 to July 2011 were selected, then they were divided into two groups according to blood calcium concentration : 11 patients in normal calcium group and 28 patients in low calcium group. The amounts of intraoperative blood loss, 24 - hour ac- cumulative amounts of blood loss after treatment, the incidences of postpartum hemorrhage, and the doses of Hemabate in the two groups were compared. Results: There was statistically significant difference in the amount of intraoperative blood loss, 24 - hour accumulative amount of blood loss after treatment, the incidence of postpartum hemorrhage, and the dose of Hemabate between the two groups ( P 〈 0. 01 ). Conclusion: The blood calcium concentration and Hemabate have synergetic effects for preventing postpartum hemorrhage.
作者 蒋晓宾
出处 《中国妇幼保健》 CAS 北大核心 2012年第28期4391-4393,共3页 Maternal and Child Health Care of China
关键词 血钙浓度 欣母沛 产后出血 Blood calcium concentration Hemabate Postpartum hemorrhage
  • 相关文献

参考文献9

二级参考文献108

  • 1丛克家,迟绍霖.钙与妊高征[J].中华妇产科杂志,1993,28(11):657-659. 被引量:158
  • 2应豪,王德芬,陈如钧.卡前列素氨丁三醇在中央性前置胎盘剖宫产时应用时间的探讨及疗效[J].中国新药与临床杂志,2005,24(3):223-224. 被引量:29
  • 3崔耀升.10%葡萄糖酸钙注射液治疗肌纤维组织炎67例[J].中国医科大学学报,1987,6(1):24-24.
  • 4Elbourne DR, Prendiville WJ, Carroli G, et al. Prophylactic use of oxytocin in the third stage of labour [ J ]. Coch Datab Syst Rev, 2001, (4) :CD001808.
  • 5Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section - A survey of practice in the United Kingdom [J]. Eur J Obstet Gynecol Reprod Biol, 2008,137( 1 ) :27-30.
  • 6Boucher M, Nimrod CA, Tawagi GF, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial[ J ]. J Obstet Gynaecol Can ,2004,26 (5) :481-488.
  • 7Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage [J]. Coeh Datab Syst Rev, 2007, 18 ( 3 ) : CD005457.
  • 8Liabsuetrakul T, Choobun T, Peeyananjarassri K,et al. Prophylactic use of ergot alkaloids in the third stage of labour[ J]. Coch Datab Syst Rev,2007, 18(2) :CD005456.
  • 9McDonald S, Abbott JM, Higgins SP. Prophylactic ergometfineoxytocin versus oxytocin for the third stage of labour [ J ]. Coch Datab Syst Rev, 2004, (1) :CD000201.
  • 10Lamont RF, Morgan D J, Logue M, et al. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage [J]. Prostaglandins Other Lipid Mediat, 2001,66 ( 3 ) : 203- 210.

共引文献477

同被引文献91

引证文献12

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部